Study objectives: To describe the clinical and radiographic findings associated with growth of Mycobacterium gordonae in cultured sputum and to determine the proportion of cases that fulfill criteria for nontuberculous mycobacterial pulmonary disease as established by the American Thoracic Society. Design: A retrospective review of charts and radiographs of all patients from whom M gordonae was isolated from sputum cultures between November 1996 and June 1998. Setting: University-affiliated Veterans Affairs hospital. Patients: Nineteen patients were identified with sputum culture positive for M gordonae. All patients had a chest radiograph within 1 month of sputum culture. Results: Sixteen patients (84%) had suppressed local and/or general immunity. Sixteen patients (84%) had respiratory symptoms, weight loss, fever, or night sweats as an indication for chest radiography. Seventeen patients (89%) had abnormal chest radiographs; however, no typical radiographic pattern was observed. No patient met diagnostic criteria for nontuberculous mycobacterial pulmonary disease as delineated by the American Thoracic Society. All patients with abnormal chest radiographs and/or respiratory symptoms ultimately had alternative explanations for their pulmonary disease. Conclusions: There is a broad spectrum of chest radiographic findings among persons with sputum culture positive for M gordonae, arguing against the presence of a characteristic chest radiograph in this patient population. M gordonae is usually a nonpathogenic colonizing organism, even among persons with local or general immune suppression and abnormal chest radiograph findings.
M
ycobacterium gordonae is typically regarded as a colonizing organism that uncommonly causes pulmonary disease in humans. 1 Found in water, this nontuberculous mycobacterium has been known as Mycobacterium aquae, and has also been included in a poorly defined group of mycobacterial strains known as "tap-water" scotochromogens. 2 It is often difficult to discern true mycobacterial infection from colonization due to this organism since M gordonae is ubiquitous and commonly an innocuous saprophyte. While M gordonae is generally viewed as having low pathogenic potential, there have been a number of limited reports of infection causing pulmonary disease in humans. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Host risk factors for either respiratory tract colonization or pulmonary disease have not, however, been defined. Abnormal lung architecture and host immunity may be important factors. 14 The primary purpose of this study was to determine whether the growth of M gordonae from cultured sputum is associated with specific clinical and radiographic features. A secondary goal was to determine the proportion of cases that fulfilled criteria for nontuberculous mycobacterial infection causing disease as established by the Scientific Assembly on Microbiology, Tuberculosis, and Pulmonary Infections (American Thoracic Society). 15 
Materials and Methods
We carried out a retrospective review of all patients from whom M gordonae was grown in sputum cultures obtained during a 20-consecutive-month period ending in June 1998 at the Veterans Affairs Palo Alto Health Care System. The study was approved by the Stanford University Administrative Panel on Human Subjects in Medical Research. The Veterans Affairs Palo Alto Health Care System is part of the United States Veterans Health Administration, which provides medical care to American military veterans. The Veterans Health Administration patient population is predominantly male.
We identified all patients with one or more sputum cultures positive for M gordonae, as detected with broth culture (BACTEC; Becton Dickinson; Towson, MD) and specific nucleic acid probe analysis (AccuProbe; Gen-Probe; San Diego, CA). 16 Sputum specimens were collected in sterile screw-top specimen cups. All microbiological analyses were performed in the Clinical Microbiology Laboratory of the Veterans Affairs Palo Alto Health Care System. The laboratory is certified by the College of American Pathologists.
Demographic and clinical data were collected from inpatient and outpatient hospital records, including the Veterans Affairs Decentralized Hospital Computer Program. Clinical data included indications for chest radiography and sputum collection, results of purified protein derivative (PPD) testing, HIV status, and history of tobacco use. Patients were classified as having local or general immune suppression if there was documentation of one or more or the following medical conditions that have been established as likely to increase the risk of developing nontuberculous mycobacterial disease: alcoholism (EtOH), bronchiectasis, cyanotic heart disease, cystic fibrosis, prior mycobacterial disease, pulmonary fibrosis, smoking, COPD, leukemia, lymphoma, organ transplantation, use of immunosuppressive therapy, or CD4 count Ͻ 200/L. 3, 15 Criteria for nontuberculous mycobacterial infection causing pulmonary disease were based on guidelines developed by the American Thoracic Society. 15 The criteria apply to symptomatic patients with nodular or cavitary disease on chest radiographs, or with multifocal bronchiectasis or small nodules on CT of the chest. The criteria include the following: three positive sputum cultures with negative acid-fast bacilli (AFB) smears, or two positive cultures with at least one positive AFB smear; one positive bronchial washing with 2 to 4 ϩ growth of mycobacteria; or biopsy positive for mycobacteria. However, these criteria apply only to disease caused by Mycobacterium avium complex (MAC), Mycobacterium kansasii, and Mycobacterium abscessus. Too little is known about pulmonary disease caused by other nontuberculous mycobacteria to validate these diagnostic criteria for other organisms. 15 Other criteria have been suggested specifically for establishing true infection by M gordonae. 14 They include multiple isolations of the organisms from the same body site or multiple sites, response of the clinical illness to antimycobacterial therapy, and elimination of the organism from clinical specimens as the illness improves.
All chest radiographs were reviewed by a single chest radiologist (P.S.) who was aware that M gordonae had been recovered from the sputa of all patients. However, he was blinded to all other clinical and demographic data for this investigation. Chest radiographs were assessed for the presence of the following abnormalities: consolidation, nodules, bronchiectasis, cavitation, reticular changes, and scarring and architectural distortion. Locations of abnormalities were categorically defined as occurring in the right or left hemithorax and upper, middle, or lower lung zones. Clinical course and outcomes were assessed by chart review up to 24 months following positive sputum culture.
Results

Demographic and Clinical Characteristics of Study Patients
We identified 19 patients from whom M gordonae was grown in sputum culture during the study period. The demographic and clinical characteristics of the patients are delineated in Table 1 . All of the patients were men, with a median age of 68 years (range, 34 to 82 years). Sixteen patients (84%) met one or more study criteria for having local or general immune suppression: COPD (n ϭ 10), EtOH (n ϭ 5), prior mycobacterial disease (n ϭ 3), pulmonary fibrosis (n ϭ 2), lymphoma (n ϭ 2), CD4 count Ͻ 200/L (n ϭ 2), and steroid use (n ϭ 1). Thirteen patients (68%) had a history of tobacco use, 7 of whom were actively smoking and 8 of whom had Ͼ 20-pack-year history. Nine patients (47%) in the study group were tested for serum antibodies to HIV; two were seropositive. All five patients admitting to IV drug use (patients 4, 6, 12, 13, and 14) were tested for serum antibodies to HIV and were negative. The two patients who were HIV seropositive met the Centers for Disease Control and Prevention clinical criteria for AIDS, based on peripheral blood CD4 lymphocyte concentration below 200/L at the time M gordonae was cultured from sputum.
Radiographic Findings
The indications for obtaining a chest radiograph in 13 patients (68%) were cough, dyspnea, or both ( Table 2) . Three of these patients also presented with hemoptysis. Other indications for chest radiography included fever (n ϭ 3), night sweats (NSW; n ϭ 3), or weight loss (n ϭ 6). Three patients had no symptoms at the time of their chest radiograph. All images were obtained within 1 month of sputum sampling for mycobacterial culture.
Radiographic abnormalities were seen in 17 patients (89%; Table 2 ). Of those radiographs that were abnormal, nine radiographs (53%) showed upper lobe abnormalities: scarring and architectural distortion (n ϭ 7), upper lobe cavities (n ϭ 5), consolida-tion (n ϭ 4), bronchiectasis (n ϭ 3), reticular changes (n ϭ 3), and nodules (n ϭ 1). Five abnormal chest radiographs (31%) showed evidence of lower lobe abnormalities: reticular changes (n ϭ 4), scarring (n ϭ 2), unilateral lower lobe cavity (n ϭ 1), bronchiectasis with consolidation (n ϭ 1), and nodules (n ϭ 1). Two patients had evidence of diffuse abnormalities, one with diffuse nodules (patient 8) and the other with diffuse reticular changes (patient 15). Two patients had right middle lobe (RML) consolidation on chest radiographs. Finally, two patients (11%) had normal chest radiographs.
Mycobacteriology
Of the 19 patients with positive sputum cultures for M gordonae, 17 patients (89%) had negative smears for AFB. Of the two patients with positive AFB smears, one patient's sputum grew Mycobacterium tuberculosis (MTB) in addition to M gordonae, and the other patient's sputum grew both M gordonae and MAC. Sixteen of the 17 patients (94%) with negative AFB smears grew exclusively M gordonae, and one patient's sputum had growth of M gordonae and Mycobacterium mucogenicum. All patients had only one sputum sample positive for M gordonae, except patients 7 and 14. Patient 7 had one of three sputum samples positive for M gordonae in each of two sets of three sputum samples, separated by one month; all six samples were AFB-smear positive and each grew MTB. Patient 14 had two of three sputum samples positive for M gordonae. Susceptibility testing of the M gordonae strains was not performed.
Patients 3, 7, 8, 9, and 13 had follow-up sputum specimens analyzed for AFB 2 weeks or more after the original isolate of M gordonae was identified. As noted above, 1 month after the original isolate was identified, follow-up sputum was positive in patient 7; however, six subsequent sputum specimens obtained over the following 4 months were negative in this patient. A total of 12 follow-up sputum specimens were obtained from the other four patients who underwent repeat sputum testing during the study period. All were negative for M gordonae, although one sputum specimen obtained from patient 8 was positive for MAC.
Histopathology was analyzed for AFB on two patients. From patient 1, stains for AFB were negative on an axillary lymph node and on pleura obtained from two different pleural biopsy procedures. From patient 12, stains for AFB were negative on lung parenchymal obtained from a wedge resection.
Testing with PPD was documented for 14 patients (74%). Seven patients were PPD negative, one of whom was anergic. The other seven patients were PPD positive, two of whom had coinfection with MTB or MAC, and five of whom had only M gordonae isolated from the sputum. Three of the latter five patients completed isoniazid prophylaxis for 6 months. 
Clinical Course and Outcomes
Five patients (26%) received antimycobacterial therapy (Table 3) . Three patients (patients 1, 7, and 10) were treated for pulmonary tuberculosis (TB), one patient (patient 8) was treated for pulmonary MAC infection, and one (patient 18) was treated for possible M gordonae infection. Patient 1 received 6 months of antituberculous therapy for presumed MTB-associated pleural effusion; however, the patient had negative pleural fluid culture, pleural biopsy, and sputum culture for MTB, and failed to demonstrate clinical or radiographic improvement after treatment. Patient 7 had known pulmonary TB and completed 6 months of antituberculous therapy with clinical improvement. Patient 10 was started on a four-drug regimen for pulmonary TB but was lost to follow-up. Patient 8 received therapy for MAC. He had an incomplete course of therapy for MAC, experienced a relapse of symptoms, and was placed back on antimycobacterial therapy. Patient 18 was the only patient in the study group treated for pulmonary disease (RUL opacities), presumably due to M gordonae infection. He was treated with isoniazid, rifampin, and ethambutol. After 6 weeks of empiric therapy, however, he failed to demonstrate clinical or radiographic improvement, and his antimycobacterial regimen was discontinued. The primary physician subsequently attributed his RUL abnormalities to possible recurrent non-small cell bronchogenic carcinoma of the lung. Serial chest radiographs over the subsequent 20 months, however, demonstrated no change in the radiographic abnormalities, arguing against the diagnosis of recurrent lung cancer. The persistent abnormalities were consistent with postlobecotomy scarring. Hemoptysis was self-limited. Anorexia and dyspnea did not progress and were likely due to severe COPD (FEV 1 ϭ 25% of predicted).
The clinicians considered the M gordonae isolated from all but one patient (patient 18) to be nonpathogenic. Of the 16 patients with radiographic abnormalities and respiratory symptoms, all had alternative explanations for their symptoms and abnormal chest radiographs, including community-acquired †Consolidation is defined as opacities Ͼ 10 mm diameter. ‡Nodules are described as p ϭ Ͻ 1.5 mm in diameter; q ϭ 1.5 to 3.0 mm, and r ϭ 3.0 to 10.0 mm. §Reticular opacities are described as s ϭ Ͻ 1 mm in diameter, t ϭ 1.0 to 3.0 mm, and u ϭ Ͼ 3.0 mm. pneumonia, TB, Pneumocystis carinii pneumonia, carcinoma, congestive heart failure, and emphysema (Table 3 ). This ultimately included patient 18, who was started on isoniazid, ethambutol, and rifampin for presumed M gordonae infection. In the two patients with normal chest radiographs, clinicians presumed they were colonized with M gordonae or their sputa were potentially contaminated with the organism. Two patients died during the study period: patient 3 died of metastatic small cell carcinoma 6 weeks after sputum analysis, and patient 16 died from congestive heart failure complicated by a left ventricular mass 1 month after sputum analysis.
Discussion
M gordonae is a ubiquitous organism that, when recovered in culture, is usually considered clinically insignificant or a contaminant. The relative paucity of reported disease due to M gordonae, despite its widespread distribution in the environment, suggests low pathogenicity. The frequency of disease caused by nontuberculous mycobacteria, however, has increased over the last several decades, especially in immunocompromised patients, including patients with cancer, AIDS, organ transplants, and those on immunosuppressive regimens. 17 M gordonae has been implicated in sporadic reports of pulmonary, soft tissue, peritoneal, corneal, and disseminated infection. 14 Prior reports of pulmonary infection caused by M gordonae have generally been limited in scope and have incompletely defined the patient population at risk. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Some reports have, however, presented clinical and microbiological data that meet proposed, although poorly validated, case definitions of nontuberculous mycobacterial pulmonary infection causing disease. 14, 15 For example, Kumar and Varkey 3 Lung infiltrates attributed to Pneumocystis carinii pneumonia, although BAL negative. Symptoms resolved after completing empiric antipneumocystis therapy. 6 Sputum analysis suggested pneumococcal pneumonia. Symptoms and radiographic abnormalities resolved with antibiotics. 7
Active pulmonary MTB was diagnosed. Symptoms resolved after 6 months of antituberculosis therapy, with persistent RUL opacity on radiography attributed to scarring. 8
Pulmonary MAC was diagnosed, with 3 consecutive sputum cultures positive for MAC. Recurrent pulmonary MAC developed 15 months later after inadequate duration of antimycobacterial treatment. Patient remains on antimycobacterial therapy with improvement in symptoms. 9
Radiographic findings were attributed to old pulmonary MTB and asbestos exposure. No specific treatment was given, and repeat chest radiographs were unchanged. 10
Active pulmonary MTB was diagnosed. Patient was started on antituberculosis therapy but lost to follow-up. 11
Acute bronchitis was clinically diagnosed, and symptoms spontaneously resolved. Patient completed 6 months isoniazid chemoprophylaxis. 12 RLL wedge resection histopathology showed organizing pneumonia and foreign body reaction consistent with aspiration pneumonia. Tissue stains were negative for AFB. Dyspnea was attributed to COPD (FEV 1 ϭ 40% of predicted). 13 RUL cavity was attributed to a bulla. Bullous disease was verified on chest CT, no specific treatment was given. 14 Staphylococcus aureus endocarditis was diagnosed. After treatment for endocarditis, repeat chest radiographs remained normal. 15 Chronic lymphocytic leukemia with lung involvement was diagnosed. Leukemia was stable on follow-up, with slow improvement in reticular lung opacities over the following 6 months. 16 Congestive heart failure developed secondary to a left ventricular mass. Patient died from progressive heart failure 2 months after diagnosis of a ventricular mass. 17
Pneumonitis was diagnosed. Symptoms slowly resolved without specific therapy. Persistent reticular lung opacities were attributed to scarring.
18
M gordonae infection was diagnosed initially. Weight loss, anorexia, and radiographic abnormalities did not resolve with 6 weeks of isoniazid, rifampin, and ethambutol therapy; Antimicrobial therapy was then discontinued. Hemoptysis was self-limited. Anorexia and dyspnea attributed to COPD (FEV 1 ϭ 25% of predicted). 19 Chest radiograph findngs were attributed to possible old granulomatous disease. Workup, including bronchoscopy and BAL of RUL, was negative; no specific treatment was instituted. Radiographic abnormalities completely resolved over 8 months of follow-up. The patient was treated with isoniazid, rifampin, ethambutol, and streptomycin (despite in vitro resistance to isoniazid and rifampin). After 5 months of treatment, sputum cultures became negative and the chest radiograph showed resolution of the area of consolidation. Treatment was discontinued at 12 months, and at 2-year follow-up she was stable with negative sputum. These reports suggest it may be inappropriate to dismiss reflexively M gordonae as a potential pulmonary pathogen; nevertheless, these scattered reports would appear to be exceptional and atypical. The aims of this study were to identify clinical and radiographic features associated with the growth of M gordonae in sputum culture and to determine whether M gordonae can be causally linked with infection causing disease in a United States military veteran patient population. To our knowledge, this is the largest case series describing patients with sputum culture positive for M gordonae.
*See
M gordonae was likely a colonizing organism in all of the 19 cases reviewed in this series. No patient in this study met the standard diagnostic criteria for nontuberculous mycobacterial pulmonary disease. 15 In each of the cases, an alternative explanation could be identified for the clinical and radiographic findings. Only 1 of the 19 patients in this study was considered (by the primary care clinician) to have possible pulmonary infection due to M gordonae (patient 18). However, there was no tissue obtained for culture or histopathology, nor were there any clinical or radiographic improvements after 6 weeks of empiric therapy in this patient.
A potential hospital environmental reservoir for M gordonae was sought, but could not be identified. During the study period, the Veterans Affairs Palo Alto Health Care System hospital epidemiologist conducted mycobacterial culture analysis of water sources in acute care patient areas and the Pulmonary Section procedure suite (personal communication; Mark Holodniy, MD; June 17, 1999). Water sources included faucets, showers, and ice machines.
All cultures were negative for M gordonae. It is unlikely that M gordonae growth in sputum cultures could be attributed to laboratory specimen crosscontamination in this study. No clear temporal pattern or clustering of positive sputa was noted during the 20 consecutive months of the study.
A second finding from this case series is that most of the patients had immune-compromising medical conditions. Previous published case reports of M gordonae causing infection have commonly been in immunocompromised persons. [3] [4] [5] 7, 8 Impaired local and general host immunity may be risk factors for both colonization and the uncommon case of infection with disease. The absence of infection causing disease observed in this case series would, however, suggest that it is unlikely that M gordonae needs to be treated, even in the immunocompromised person. An alternative explanation for respiratory symptoms and radiographic abnormalities should always be pursued. This is not to suggest that M gordonae is incapable of causing infection. In other retrospective studies, M gordonae isolated from HIV-positive patients was usually determined to be nonpathogenic. However, in rare cases among patients with AIDS, M gordonae has been causally linked with pulmonary disease. 10, 11 Others have reported disseminated M gordonae in AIDS. 11, 18, 19 This case series, however, strongly suggests that a diagnosis of M gordonae infection causing pulmonary disease should generally be regarded as a diagnosis of exclusion.
A third finding from this case series is that a spectrum of radiographic findings was observed, including both upper and lower lung zone abnormalities and normal lung architecture. The wide spectrum of radiographic abnormalities observed in this study argues against a characteristic radiographic picture among persons with sputum culture positive for M gordonae. Pulmonary disease due to other nontuberculous mycobacteria, including MAC, Mycobacterium xenopi, and Mycobacterium malmoense, typically presents as nodular or cavitary disease on chest radiographs. 15 In contrast with chest radiographs of persons with MTB infection, chest radiographs of persons with these nontuberculous mycobacterial infections reveal thin-walled cavities, less surrounding consolidation, and more thickening of the overlying pleura. 15, 20 A number of different chest radiographic findings have been described in sporadic cases of pulmonary infection due to M gordonae, including unilateral upper lobe cavity, 3, 4 unilateral lower lobe cavity, 5 bilateral apical cavities, 6 upper lobe consolidation, 7 and lower lobe consolidation. 8 However, "typical" chest radiographic findings for pulmonary infection or colonization by M gordonae have not been described.
Conclusion
The growth of M gordonae from sputum culture among all patients in this study population represented microbial colonization and not infection causing disease. Medical conditions causing local or general immune suppression are common among persons with respiratory tract colonization by M gordonae. Even among persons with immune-compromising illnesses, treatment of M gordonae is usually not necessary. Individuals with sputum culture positive for M gordonae do not appear to have a characteristic chest radiographic finding. An alternative explanation for respiratory symptoms and radiographic abnormalities should always be pursued.
